Skip to main content
Log in

Cell models and drug discovery for mitochondrial diseases

线粒体疾病细胞模型及其药物筛选

  • Review
  • Published:
Journal of Zhejiang University-SCIENCE B Aims and scope Submit manuscript

Abstract

Mitochondrion is a semi-autonomous organelle, important for cell energy metabolism, apoptosis, the production of reactive oxygen species (ROS), and Ca2+ homeostasis. Mitochondrial DNA (mtDNA) mutation is one of the primary factors in mitochondrial disorders. Though much progress has been made, there remain many difficulties in constructing cell models for mitochondrial diseases. This seriously restricts studies related to targeted drug discovery and the mechanism and therapy for such diseases. Here we summarize the characteristics of patient-specific immortalized lymphoblastoid cells, fibroblastoid cells, cytoplasmic hybrid (cybrid) cell lines, and induced pluripotent stem cells (iPSCs)-derived differentiation cells in the study of mitochondrial disorders, as well as offering discussion of roles and advances of these cell models, particularly in the screening of drugs.

概 要

线粒体是一种半自主性细胞器, 不仅是细胞能量代谢的重要场所, 而且与细胞凋亡、 活性氧 (ROS) 产生和 Ca2+ 稳态等密切相关。 线粒体 DNA (mtDNA) 突变是线粒体疾病发生的重要原因。 当前, 线粒体疾病细胞模型构建仍存在许多困难, 严重制约线粒体疾病的致病机制、 靶向药物筛选和临床治疗等研究。 本文将重点介绍线粒体疾病细胞模型的构建和特征, 包括患者特异性永生化淋巴细胞模型、 成纤维细胞模型及其衍生的转线粒体细胞模型和诱导多能干细胞及其定向分化细胞模型, 以及这些细胞模型在线粒体药物筛选中的作用和研究进展。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Download references

Acknowledgments

We thank Chris WOOD of the College of Life Sciences Zhejiang University (Hangzhou, China) for checking the English of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xu-fen Zhu or Qing-feng Yan.

Additional information

Project supported by the National Basic Research Program of China (No. 2014CB943001), the National Natural Science Foundation of China (Nos. 31771398 and 31571299), the Fundamental Research Funds for the Central Universities (No. 2019QNA6001), and the Zhejiang Provincial Natural Science Foundation of China (Nos. LZ19C060001 and LY14C060004)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, Sy., Zhuang, Qq., Qiu, Y. et al. Cell models and drug discovery for mitochondrial diseases. J. Zhejiang Univ. Sci. B 20, 449–456 (2019). https://doi.org/10.1631/jzus.B1900196

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B1900196

Key words

关键词

CLC number

Navigation